Table 1.
Cancer types | Osteoblast-secreted factors | Mechanisms | Reference |
---|---|---|---|
Human breast cancer cells | Direct interaction | N/A | [25] |
Primary breast cancer cells | ↑ KLF7, THY1, PECA1, and PLAUR; ↓ BMI1 and ID1 | [22] | |
Breast cancer cells | ↑ Notch2 signalling | [26] | |
Myeloma cells | Type-I collagen | N/A | [21] |
Primary leukaemia cells | OPN | ↑ cell cycle exit | [23] |
Prostate cancer cells | BMP7 | ↑ NDRG1 mRNA expression via activating p38 and p21 | [27] |
Prostate cancer cells | Wnt5a | ↑ SIAH2/ROR2 signalling axis; ↓ Wnt/β-catenin signalling | [28] |
Prostate cancer cells | TGFβ2 | ↑ TGFβRIII signalling; ↑ p38MAPK phosphorylation and nuclear translocation; ↑ pS249/pT252-RB in the nucleus; ↑ p27 and G1-cell cycle arrest | [20] |
Breast cancer cells | LIF | Binding to LIFR and ↑ gene expressions of TSP1, TPM1, TGFβ2, P4HA1, miR-190 and SELENBP1 | [29] |
Cancer cells | CXCL12 | Binding to CXCR4 in tumour cells and ↑ drug resistance | [30, 31] |
Prostate cancer cells | Gas6 | ↑ Axl, Sky and Mer | [32] |
Note: ‘↑’ represents increased, upregulated, induced, enhanced and activated; While ‘↓’ represents decreased, downregulated, inhibited; N/A represents not applicable